KYLIE THIBODEAUX: Open Payments
NPI 1992092019 · OPELOUSAS, LA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$563 in 15 payments from 6 companies in 2025. Trend: 2023 $213 · 2024 $161 · 2025 $563
Food & beverage: $365Education: $198
| Company | Payments | Amount |
|---|---|---|
| Astellas Pharma US Inc | 5 | $324 |
| MAYNE PHARMA COMMERCIAL LLC | 3 | $91 |
| MILLICENT US INC | 2 | $51 |
| Axsome Therapeutics, Inc. | 2 | $40 |
| Lilly USA, LLC | 2 | $39 |
| Sumitomo Pharma America, Inc. | 1 | $18 |
Products named: Veozah, Auvelity, INTRAROSA, JARDIANCE, FEMLYV, MYFEMBREE, MOUNJARO.
Industry payments across LA — which companies pay providers there.
